Implications of US Trade Policies on Swiss Economy
While Switzerland has so far avoided direct impacts from Trump’s tariff wars, the nation was listed alongside other countries believed to employ “unfair” trade practices by the United States. This designation centers primarily on Switzerland’s trade surplus in goods, with the US conveniently ignoring its own surplus in services.
Concerns about potential tariffs have unsettled the Swiss stock market, sparking fears of reduced profits for Swiss exporters. Senior Investment Manager Lorenz Reinhard from Pictet points out that US bureaucracy reduction efforts may have harsher impacts. President Trump’s reliance on figures like Elon Musk has already indirectly affected Swiss companies. For instance, Sonova, the largest hearing aid manufacturer in the world, has seen its share drop by nine percent since the start of the year due to an uncertain US market.
How Large Corporations Shield Themselves from Zollrisks
Swiss giants, such as the lab equipment provider Tecan—recording about 60% of its earnings from the US—have felt the repercussions of Trump’s cuts to the National Health Institutes’ research budgets. These cuts have diminished demand for lab instruments, resulting in a 17% decline of Tecan’s stock value in just one month.
Brewing anxiety persists for other medtech firms like Bachem and Ypsomed. However, large pharmaceutical firms Roche and Novartis seem to weather US policy turbulence better. They counterbalance US market exposure with domestic manufacturing capabilities, buffering the potential shock of tariffs.
Investment advisor Reinhard attributes the success of Roche to its non-cyclical business model, with healthcare necessities staying unaffected by economic downturns. The company’s strong position, post-patent expiry stress, forecasts robust growth, especially with advancements in weight-loss medications.
Nestlé’s Remarkable Recovery
In stark contrast to its initial 2024 losses, Nestlé bounced back robustly, lifting its stock price by almost 19% to 89 Swiss francs in just one year. Improved quarterly results initially catalyzed this recovery, amplified by its status as a safe investment during the US recession anxieties. Alongside Roche, Nestlé propelled the Swiss Market Index by 11% to around 13,000 points from the start of the year.
UBS in a Quandary Below Peers
UBS has lagged behind its European banking counterparts, recording only a modest 3% rise in stock value. This subdued performance results from uncertainty over the capital requirements following its takeover of Credit Suisse, impacting potential investor benefits like stock buybacks and dividend payouts. The outcome may pivot on the Swiss government’s mid-May capital strategy disclosures, with the final decision lying with the parliament.
Growing Opportunities in German Infrastructure
Swiss businesses, such as Geberit, Sika, and Schindler, stand poised to capitalize on Germany’s extensive infrastructure program. Geberit, in particular, has already seen its stock soar 14% this year, likely anticipating lucrative cross-border business opportunities.
FAQs About Swiss Market Trends
How are Swiss companies adapting to US trade policy changes? Companies are diversifying and reinforcing domestic capabilities to buffer against trade uncertainties.
Which sectors show resilience in the Swiss market? Healthcare and luxury goods, particularly pharmaceuticals and food sectors like Nestlé, demonstrate resilience due to consistent global demand.
What potential risks exist for Swiss banks like UBS? Increased regulatory capital requirements could limit financial maneuverability, impacting stock and dividend performance.
Did you know? The Swiss stock market’s stability makes it a safe haven in turbulent economic times.
Pro Tips for Investors
- Monitor US trade policy developments for potential indirect impacts on Swiss firms.
- Focus on Swiss companies with substantial domestic production when investing in pharmaceuticals and medtech.
- Consider opportunities in German infrastructure projects, which provide a growing market for Swiss companies.
Further Engagement
Engage with us and explore more insightful analyses by following our weekly updates. Consider subscribing to our newsletter for the latest industry insights and perspectives.
Keep reading